Tissue- and development-stage–specific mRNA and heterogeneous CNV signatures of human ribosomal proteins in normal and cancer samples. Issue 13 (11th June 2020)

• Record Type: Journal Article
• Authors: Panda, Anshuman; Yadav, Anupama; Yeerna, Huwate; Singh, Amartya; Biehl, Michael; Lux, Markus; Schulz, Alexander; Klecha, Tyler; Doniach, Sebastian; Khiabanian, Hossein; Ganesan, Shridar; Tamayo, Pablo; Bhanot, Gyan
• Is Part Of: Nucleic acids research. Volume 48:Issue 13(2020)
• Page Start: 7079
• Page End: 7098
• Publication Date: 2020-06-11
• Subjects: Nucleic acids -- Periodicals; Molecular biology -- Periodicals; 572.805
• DOI: 10.1093/nar/gkaa485
• Languages: English
• ISSNs: 0305-1048

Abstract

Abstract: We give results from a detailed analysis of human Ribosomal Protein (RP) levels in normal and cancer samples and cell lines from large mRNA, copy number variation and ribosome profiling datasets. After normalizing total RP mRNA levels per sample, we find highly consistent tissue specific RP mRNA signatures in normal and tumor samples. Multiple RP mRNA-subtypes exist in several cancers, with significant survival and genomic differences. Some RP mRNA variations among subtypes correlate with copy number loss of RP genes. In kidney cancer, RP subtypes map to molecular subtypes related to cell-of-origin. Pan-cancer analysis of TCGA data showed widespread single/double copy loss of RP genes, without significantly affecting survival. In several cancer cell lines, CRISPR-Cas9 knockout of RP genes did not affect cell viability. Matched RP ribosome profiling and mRNA data in humans and rodents stratified by tissue and development stage and were strongly correlated, showing that RP translation rates were proportional to mRNA levels. In a small dataset of human adult and fetal tissues, RP protein levels showed development stage and tissue specific heterogeneity of RP levels. Our results suggest that heterogeneous RP levels play a significant functional role in cellular physiology, in both normal and disease states.